Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Pancreatic Neoplasms 2Urethral Neoplasms 1Ureteral Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Papillomavirus Infections 1Ovarian Neoplasms 1Hydronephrosis 1Carcinoma, Renal Cell 1Breast Neoplasms 1Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

durvalumab 1Receptor Protein-Tyrosine Kinases 1Immunoglobulin G 1Disulfides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Papillomavirus Infections × Immunoglobulin G × Clear all
NCT02827838 2025-03-17

Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer

Wake Forest University Health Sciences

Phase EARLY_PHASE1 Terminated
17 enrolled 12 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡